224 related articles for article (PubMed ID: 20504100)
21. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.
Rebar R; Judd HL; Yen SS; Rakoff J; Vandenberg G; Naftolin F
J Clin Invest; 1976 May; 57(5):1320-9. PubMed ID: 770505
[TBL] [Abstract][Full Text] [Related]
22. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
[TBL] [Abstract][Full Text] [Related]
23. Effects of ovarian drilling in middle Black Sea region Turkish women with polycystic ovary syndrome having normal and high body mass indices.
Demirturk F; Caliskan AC; Aytan H; Erkorkmaz U
J Obstet Gynaecol Res; 2006 Oct; 32(5):507-12. PubMed ID: 16984519
[TBL] [Abstract][Full Text] [Related]
24. The role of plasma renin activity in distinguishing patients with polycystic ovary syndrome (PCOS) from oligomenorrheic patients without PCOS.
Uncu G; Sözer MC; Develioğlu O; Cengiz C
Gynecol Endocrinol; 2002 Dec; 16(6):447-52. PubMed ID: 12626031
[TBL] [Abstract][Full Text] [Related]
25. Free testosterone, luteinizing hormone/follicle stimulating hormone ratio and pelvic sonography in relation to skin manifestations in patients with polycystic ovary syndrome.
Sharquie KE; Al-Bayatti AA; Al-Ajeel AI; Al-Bahar AJ; Al-Nuaimy AA
Saudi Med J; 2007 Jul; 28(7):1039-43. PubMed ID: 17603706
[TBL] [Abstract][Full Text] [Related]
26. [Association of monocyte chemoattractant protein-1 and the clinical characteristics of polycystic ovary syndrome: analysis of 65 cases].
Hu WH; Qiao J; Li MZ
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(11):721-4. PubMed ID: 17565837
[TBL] [Abstract][Full Text] [Related]
27. [Preliminary study on the value of ratio of serum luteinizing hormone/follicle-stimulating hormone in diagnosis of polycystic ovarian syndrome among women with polycystic ovary].
Ma CS; Lin Y; Zhang CH; Xu H; Li YF; Zhang SC; Tan Y; Quan S; Xing FQ
Zhonghua Fu Chan Ke Za Zhi; 2011 Mar; 46(3):177-80. PubMed ID: 21575449
[TBL] [Abstract][Full Text] [Related]
28. Effect of obesity on the clinical and hormonal characteristics of the polycystic ovary syndrome.
Singh KB; Mahajan DK; Wortsman J
J Reprod Med; 1994 Oct; 39(10):805-8. PubMed ID: 7837128
[TBL] [Abstract][Full Text] [Related]
29. Characterization of pulsatile secretion of gonadotropin and prolactin in women with normal menstrual cycle, secondary amenorrhea and polycystic ovary syndrome (PCOS).
Lin KC; Lee JN
Kaohsiung J Med Sci; 1998 Feb; 14(2):61-7. PubMed ID: 9542361
[TBL] [Abstract][Full Text] [Related]
30. Subcutaneous administration of pulsatile gonadotropin-releasing hormone decreases serum follicle-stimulating hormone and luteinizing hormone levels in women with polycystic ovary syndrome: a preliminary study.
Graña-Barcia M; Liz-Lestón J; Lado-Abeal J
Fertil Steril; 2005 May; 83(5):1466-72. PubMed ID: 15866586
[TBL] [Abstract][Full Text] [Related]
31. Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome.
Fenkci SM; Fenkci V; Oztekin O; Rota S; Karagenc N
Hum Reprod; 2008 Jul; 23(7):1602-6. PubMed ID: 18378560
[TBL] [Abstract][Full Text] [Related]
32. [Effects of metformin on gonadotropin-induced ovulation in patients with polycystic ovary syndrome].
Zhao JZ; Ye BL; Lin JJ; Lin WQ; Chi HH
Zhonghua Fu Chan Ke Za Zhi; 2003 Sep; 38(9):545-8. PubMed ID: 14680609
[TBL] [Abstract][Full Text] [Related]
33. Follicle Stimulating Hormone (LH: FSH) Ratio in Polycystic Ovary Syndrome (PCOS) - Obese vs. Non- Obese Women.
Saadia Z
Med Arch; 2020 Aug; 74(4):289-293. PubMed ID: 33041447
[TBL] [Abstract][Full Text] [Related]
34. Comparison of fibrinolytic and metabolic system parameters in obese patients with polycystic ovary syndrome and women with simple obesity.
Słopień R; Lewandowski K; Kolacz E; Zawilska K; Warenik-Szymankiewicz A
Gynecol Endocrinol; 2006 Nov; 22(11):651-4. PubMed ID: 17145652
[TBL] [Abstract][Full Text] [Related]
35. Variability of serum gonadotropin and dehydroepiandrosterone sulfate concentrations in women with polycystic ovary syndrome.
Oei ML; Kazer RR
J Reprod Med; 1992 Dec; 37(12):974-8. PubMed ID: 1287208
[TBL] [Abstract][Full Text] [Related]
36. A new approach in the evaluation of gonadotropins for the diagnosis of polycystic ovary syndrome.
Manieri C; Pastorino R; Marolda AR; Musso M; Boggio G; Fornengo R; Tagliabue M; Di Bisceglie C; Camanni F
Panminerva Med; 1995 Sep; 37(3):115-8. PubMed ID: 8869364
[TBL] [Abstract][Full Text] [Related]
37. Influence of adiposity on leptin, LH and androgen levels in lean, overweight and obese PCOS patients.
LaZovic G; Radivojevic U; Milicevic S; Spremovic S
Int J Fertil Womens Med; 2007; 52(2-3):82-8. PubMed ID: 18320865
[TBL] [Abstract][Full Text] [Related]
38. Body mass index and gonadotropin hormones (LH & FSH) associate with clinical symptoms among women with polycystic ovary syndrome.
Esmaeilzadeh S; Andarieh MG; Ghadimi R; Delavar MA
Glob J Health Sci; 2014 Sep; 7(2):101-6. PubMed ID: 25716399
[TBL] [Abstract][Full Text] [Related]
39. Factors affecting the degree of hirsutism in patients with polycystic ovary syndrome.
Guzel AI; Kuyumcuoğlu U; Celik Y
Arch Gynecol Obstet; 2012 Mar; 285(3):767-70. PubMed ID: 21909749
[TBL] [Abstract][Full Text] [Related]
40. [Polycystic ovary syndrome associated with remarkable hyperprolactinemia--case report].
Owecki M; Sowiński J
Pol Merkur Lekarski; 2004 Oct; 17(100):385-7. PubMed ID: 15690710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
